Phosphoramidic Acid

Phosphoramidic Acid

SCHEMBL2236409

CCC[n+]1cc[nH]c1C.CCC[n+]1cc[nH]c1C.NP(=O)([O-])[O-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623161 0.86
Phosphoric Acid SCHEMBL14164747 0.85 GGPS1 (0.31)
Iodide SCHEMBL379644 0.84
Iodide SCHEMBL5538012 0.84
SCHEMBL16701174 0.83
Acetic Acid SCHEMBL28811867 0.81
SCHEMBL16700934 0.81
SCHEMBL31207553 0.79
Trifluoroacetic Acid SCHEMBL16700650 0.78 CCR5 (0.33)
Trifluoromethanesulfonic Acid SCHEMBL5950265 0.78 KCNH2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2193204-B1 COMPOSITIONS COMPRISING LIPOPHOSPHORAMIDES AND THEIR USES IN GENE THERAPY UNIV BRETAGNE OCCIDENTALE (FR) 2011-08-31 EP disclosed
EP-2193204-A2 NOVEL LIPOPHILIC COMPOSITIONS AND USES THEREOF Universite de Bretagne Occidentale (FR) 2010-06-09 EP disclosed
WO-2009050372-A2 NOVEL LIPOPHILIC COMPOSITIONS AND USES THEREOF UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) 2009-04-23 WO disclosed